Overhaul of US drug policy is long overdue, expert says

March 9, 2017 by David Ruth
Overhaul of US drug policy is long overdue, expert says
Credit: shutterstock.com/Rice University

A new report from the Office of the Surgeon General, "Facing Addiction in America," suggests that an overhaul of U.S. drug policy is long overdue, according to a new issue brief from a drug policy expert at Rice University's Baker Institute for Public Policy.

The 's report is meant to be a call to action against the public health crisis of , according to the brief's author, Katharine Neill, the Baker Institute's Alfred C. Glassell III Postdoctoral Fellow in Drug Policy. It brings an authoritative voice to the current national debate over how to confront addiction in the face of rising rates of opioid-related overdoses and confirms what many observers have claimed—that addiction requires compassion and treatment, not punishment, she said.

"The strong endorsement from the surgeon general's office for integrated substance use care, expanded use of medication-assisted treatment and an overall public-health-based approach to addiction should send a clear message to policymakers and the public that an overhaul of U.S. is long overdue," Neill wrote.

The report is densely packed with troubling statistics that highlight the prevalence of alcohol and in the United States, Neill said. In 2015, 20.8 million people—nearly 8 percent of the U.S. population—met the criteria for a substance use disorder (SUD) involving alcohol or illicit substances. As the report states, roughly 88,000 deaths per year are alcohol-related. In 2015, more than 52,000 deaths were attributed to drug overdose, which has claimed more lives in recent years largely due to a rise in opioid misuse. Substance misuse and SUDs cost the United States roughly $400 billion annually in health care and criminal justice expenses and lost worker productivity.

Despite the heavy toll of substance misuse on individuals, families and society, only about 10 percent of people who need help with an SUD actually receive it, Neill said. "In the face of this crisis and based on a growing body of neurobiological evidence, the report argues that addiction is a chronic disease of the brain that should be treated more like diabetes and less like an act of criminal misconduct," Neill wrote.

Neill's brief, "Will the Surgeon General's Report on Addiction Change How We Treat Drug Users?", analyzes the major claims and implications of the report and proposes additional drug policy considerations for addressing substance use disorders."

"For all its admirable qualities, there are other areas in which the report falls short," Neill wrote. "It misses an opportunity to bring heroin-assisted treatment into the discussion of effective medication-assisted therapies for opioid use disorders. While it argues that addiction should not be criminalized, it stops short of supporting decriminalization of drug possession and maintains that legal sanctions can be an effective incentive for drug treatment, not dealing with the reality of how these sanctions might be used in practice and the collateral consequences that an individual faces if sanctions are enforced."

Neill said future efforts to address should frame neurobiological explanations of addiction more squarely within the context of environmental risk factors and should emphasize the need for social policies that address the underlying external causes of addiction.

"It is indeed time to change how we view drug addiction," Neill wrote. "Let's get it right this time—by acknowledging the many complexities of addiction and the need for a holistic policy response."

Explore further: Treat synthetic cannabinoids as public health issue, report says

Related Stories

New charts provide picture of drug use in the United States

August 15, 2016

An extensive and easy-to-use collection of charts that present findings from decades of government survey data of drug use in the United States is now available on the website of Rice University's Baker Institute for Public ...

Pediatric workforce must address opioid crisis

October 3, 2016

In late August, the American Academy of Pediatrics (AAP) called on providers who care for youth to offer the same treatments routinely offered to adults - including medications like buprenorphine (commonly known by its brand ...

Recommended for you

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Mar 10, 2017
The surgeon general is an incompetent. A single dose of 250mg of healthy adult male facial skin surface lipid taken by mouth (the pheromone is usually passed in kissing), alleviates addiction without withdrawal symptoms for at least two years.
The collected pheromone is a behavioral biohazard, causing stupidity, incompetence, arrogance, suspicion, and in higher doses, jealousy. Osculation partners of treated addicts inevitably become artificially jealous. 40 day isolation, supplied air respirators for staff, and sealed packaging with activated charcoal dunnage for the collected male facial skin surface pheromone is indicated. It takes about 40 days for the pheromone to wear off the saliva of the treated former addict.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.